MEDICAPS

MediCaps Share Price

₹41.46 -1.02 (-2.4%)

31 Mar, 2025 10:30

SIP TrendupStart SIP in MEDICAPS

Start SIP

Performance

  • Low
  • ₹41
  • High
  • ₹44
  • 52 Week Low
  • ₹41
  • 52 Week High
  • ₹61
  • Open Price₹42
  • Previous Close₹42
  • Volume3,719

Investment Returns

  • Over 1 Month -14.43%
  • Over 3 Month -14.29%
  • Over 6 Month -18.08%
  • Over 1 Year -6.47%
SIP Lightning

Smart Investing Starts Here Start SIP with MediCaps for Steady Growth!

Invest Now

MediCaps Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • -15.4
  • PEG Ratio
  • 0
  • Market Cap Cr
  • 52
  • P/B Ratio
  • 0.4
  • Average True Range
  • 2.88
  • EPS
  • -
  • Dividend Yield
  • 0
  • MACD Signal
  • -0.75
  • RSI
  • 35.9
  • MFI
  • 14.48

MediCaps Financials

MediCaps Technicals

EMA & SMA

Current Price
₹41.46
-1.02 (-2.4%)
  • stock-down_img
  • Bearish Moving Average 0
  • stock-up_img
  • Bullish Moving Average 0
  • 20 Day
  • ₹45.13
  • 50 Day
  • ₹46.78
  • 100 Day
  • ₹48.21
  • 200 Day
  • ₹48.89

Resistance and Support

42.2 Pivot Speed
  • R3 45.22
  • R2 44.44
  • R1 42.98
  • S1 40.74
  • S2 39.96
  • S3 38.50

What's your outlook on MediCaps?

You can only vote for once

MediCaps Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2025-02-12 Quarterly Results
2024-11-12 Quarterly Results
2024-08-07 Quarterly Results
2024-05-23 Quarterly Results
2024-02-08 Quarterly Results

MediCaps F&O

MediCaps Shareholding Pattern

No data available.

About MediCaps

  • NSE Symbol
  • MEDICAPS
  • BSE Symbol
  • 523144
  • ISIN
  • INE442D01010

Similar Stocks to MediCaps

MediCaps FAQs

MediCaps share price is ₹41 As on 31 March, 2025 | 10:16

The Market Cap of MediCaps is ₹51.7 Cr As on 31 March, 2025 | 10:16

The P/E ratio of MediCaps is -15.4 As on 31 March, 2025 | 10:16

The PB ratio of MediCaps is 0.4 As on 31 March, 2025 | 10:16

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23